High resolution proton MR spectroscopy of cerebrospinal fluid in MS patients. Comparison with biochemical changes in demyelinating plaques.
about
Multi-platform characterization of the human cerebrospinal fluid metabolome: a comprehensive and quantitative updateMyalgic encephalomyelitis/chronic fatigue syndrome and encephalomyelitis disseminata/multiple sclerosis show remarkable levels of similarity in phenomenology and neuroimmune characteristicsMetabolomic profiling in multiple sclerosis: insights into biomarkers and pathogenesisInflammatory multiple-sclerosis plaques generate characteristic metabolic profiles in cerebrospinal fluidFluvoxamine stimulates oligodendrogenesis of cultured neural stem cells and attenuates inflammation and demyelination in an animal model of multiple sclerosis.Energy failure in multiple sclerosis and its investigation using MR techniques.Cross-platform analysis of longitudinal data in metabolomics.Angiogenesis in multiple sclerosis and experimental autoimmune encephalomyelitis.Axonal damage in multiple sclerosis.Localised 1H-MR spectroscopy for metabolic characterisation of diffuse and focal brain lesions in patients infected with HIV.Cerebrospinal fluid lactate is associated with multiple sclerosis disease progression.Cerebrospinal fluid evidence of increased extra-mitochondrial glucose metabolism implicates mitochondrial dysfunction in multiple sclerosis disease progression.(1)H-NMR analysis provides a metabolomic profile of patients with multiple sclerosis.Metabolomic profiling of CSF in multiple sclerosis and neuromyelitis optica spectrum disorder by nuclear magnetic resonance.CSF profile in primary progressive multiple sclerosis: Re-exploring the basics.Hyperpolarized 13C MR metabolic imaging can detect neuroinflammation in vivo in a multiple sclerosis murine model.The pattern of proton magnetic resonance spectroscopy in non-neoplastic encephalic lesions.Proton nuclear magnetic resonance-based metabonomics for rapid diagnosis of meningitis and ventriculitis.Metabolic changes in neuronal migration disorders: evaluation by combined MRI and proton MR spectroscopy.Histopathology and serial, multimodal magnetic resonance imaging in a multiple sclerosis variant.Loss of lysophosphatidic acid receptor LPA1 alters oligodendrocyte differentiation and myelination in the mouse cerebral cortex.Alternating hemisphere tumefactive demyelinating disorder.Demyelination in Multiple Sclerosis: Reprogramming Energy Metabolism and Potential PPARγ Agonist Treatment Approaches.
P2860
Q21183970-9BD7BD49-376A-4E8B-A4D2-360983A31363Q26998412-8E0C7228-1FFC-40BF-ADD3-8AB92501CC63Q28306726-5F3EFD13-D72D-42FB-9BD2-668B2AFA6309Q28469239-D1B895D2-7DD9-4E5C-8F0B-6A78F124EDF7Q33884949-31982948-74E2-4F61-9588-FE54B4FA8F84Q33928808-6D69295C-7704-43CB-80E4-857DC7D96A65Q34030471-4B96AA41-9839-447C-9CB2-95C0BB01186AQ34109028-CA3C4DDC-5A94-40B9-9AC3-8BA200CCED45Q35126104-A9BD7E92-2667-46D5-AC29-3C56DA6FD272Q36318124-DA754A38-F359-47B3-BF36-68DF3FEC809CQ36570149-071FECD6-E1C1-48D1-BB1D-C91D4A9E9E8BQ36975562-7E34BC41-0114-48B3-A9D2-10015461535EQ40133625-FDB0D167-359E-4F16-8444-4CDF192E647FQ41137046-AE838CC2-C4C9-469C-9829-C4C29A25AA1BQ41349564-73F826A9-080A-437F-BFC3-745C10A647D9Q41476817-6A6EC0C1-2D8B-4A86-ABE7-CB6F6D1B2401Q44992900-C9724B68-081A-40EB-8767-15325AE4E892Q45005560-4C4978EB-7B41-46E5-B237-68EF5B6A432DQ48165227-DA7C14CF-D121-4061-AEA4-7997C85BB779Q48186713-3C27838C-E823-48D1-869B-576EF1942E51Q48538814-6566931E-8323-41D6-8B06-73EB8DAAE19AQ53572123-8CB842B1-9346-460A-BA55-EC670D2469BBQ55088439-65987693-271A-41CA-812B-50548CAA69DB
P2860
High resolution proton MR spectroscopy of cerebrospinal fluid in MS patients. Comparison with biochemical changes in demyelinating plaques.
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年学术文章
@wuu
1996年学术文章
@zh
1996年学术文章
@zh-cn
1996年学术文章
@zh-hans
1996年学术文章
@zh-my
1996年学术文章
@zh-sg
1996年學術文章
@yue
1996年學術文章
@zh-hant
name
High resolution proton MR spec ...... nges in demyelinating plaques.
@en
High resolution proton MR spec ...... nges in demyelinating plaques.
@nl
type
label
High resolution proton MR spec ...... nges in demyelinating plaques.
@en
High resolution proton MR spec ...... nges in demyelinating plaques.
@nl
prefLabel
High resolution proton MR spec ...... nges in demyelinating plaques.
@en
High resolution proton MR spec ...... nges in demyelinating plaques.
@nl
P2093
P50
P1476
High resolution proton MR spec ...... nges in demyelinating plaques.
@en
P2093
Federico F
Giannini P
Picciola E
Tortorella C
P304
P356
10.1016/S0022-510X(96)00224-9
P577
1996-12-01T00:00:00Z